98 related articles for article (PubMed ID: 15015616)
1. The impact of stromal cell contamination on chemosensitivity testing of head and neck carcinoma.
Dollner R; Granzow C; Helmke BM; Ruess A; Schad A; Dietz A
Anticancer Res; 2004; 24(1):325-31. PubMed ID: 15015616
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo responsiveness of head and neck squamous cell carcinoma to vinorelbine.
Dollner R; Granzow C; Tschop K; Dietz A
Anticancer Res; 2006; 26(3B):2361-5. PubMed ID: 16821617
[TBL] [Abstract][Full Text] [Related]
3. Ex vivo chemosensitivity of head and neck carcinoma to cytostatic drug combinations.
Dollner R; Granzow C; Neudert M; Dietz A
Anticancer Res; 2006; 26(2B):1651-5. PubMed ID: 16619587
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of epithelial and stromal cells of head and neck squamous cell carcinomas in ex vivo chemoresponse.
Horn IS; Wichmann G; Mozet C; Dietz A; Dollner R; Tschöp K; Boehm A
Cancer Chemother Pharmacol; 2010 May; 65(6):1153-63. PubMed ID: 19771432
[TBL] [Abstract][Full Text] [Related]
5. Single tissue samples from head and neck squamous cell carcinomas are representative regarding the entire tumor's chemosensitivity to cisplatin and docetaxel.
Wichmann G; Horn IS; Boehm A; Mozet C; Tschop K; Dollner R; Dietz A
Onkologie; 2009 May; 32(5):264-72. PubMed ID: 19420973
[TBL] [Abstract][Full Text] [Related]
6. Prediction of chemosensitivity using multigene analysis in head and neck squamous cell carcinoma.
Hasegawa Y; Goto M; Hanai N; Ijichi K; Terada A; Hyodo I; Ogawa T; Fukushima M
Oncology; 2007; 73(1-2):104-11. PubMed ID: 18337622
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo responsiveness of head and neck squamous cell carcinoma to glufosfamide, a novel alkylating agent.
Dollner R; Dietz A; Kopun M; Helbig M; Wallner F; Granzow C
Anticancer Res; 2004; 24(5A):2947-51. PubMed ID: 15517901
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of optimal drug concentration in histoculture drug response assay in association with clinical efficacy for head and neck cancer.
Hasegawa Y; Goto M; Hanai N; Ijichi K; Adachi M; Terada A; Hyodo I; Ogawa T; Furukawa T
Oral Oncol; 2007 Sep; 43(8):749-56. PubMed ID: 17112769
[TBL] [Abstract][Full Text] [Related]
9. Correlations between thymidylate synthase expression and chemosensitivity to 5-fluorouracil, cell proliferation and clinical outcome in head and neck squamous cell carcinoma.
Yasumatsu R; Nakashima T; Uryu H; Ayada T; Wakasaki T; Kogo R; Masuda M; Fukushima M; Komune S
Chemotherapy; 2009; 55(1):36-41. PubMed ID: 19023200
[TBL] [Abstract][Full Text] [Related]
10. Cyclin A as a predictive factor for chemotherapy response in advanced head and neck cancer.
Rodriguez-Pinilla M; Rodriguez-Peralto JL; Hitt R; Sanchez JJ; Ballestin C; Diez A; Sanchez-Verde L; Alameda F; Sanchez-Cespedes M
Clin Cancer Res; 2004 Dec; 10(24):8486-92. PubMed ID: 15623629
[TBL] [Abstract][Full Text] [Related]
11. [Basic and clinical evaluation of the effect of pirarubicin against head and neck cancer--chemosensitivity test and a comparative study with doxorubicin].
Nakashima T; Masuda A; Yano G; Maehara Y
Gan To Kagaku Ryoho; 1994 Apr; 21(5):633-9. PubMed ID: 8154889
[TBL] [Abstract][Full Text] [Related]
12. Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma.
Katayama A; Ogino T; Bandoh N; Nonaka S; Harabuchi Y
Clin Cancer Res; 2005 Apr; 11(8):2937-46. PubMed ID: 15837745
[TBL] [Abstract][Full Text] [Related]
13. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
[TBL] [Abstract][Full Text] [Related]
14. Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting.
Sok JC; Coppelli FM; Thomas SM; Lango MN; Xi S; Hunt JL; Freilino ML; Graner MW; Wikstrand CJ; Bigner DD; Gooding WE; Furnari FB; Grandis JR
Clin Cancer Res; 2006 Sep; 12(17):5064-73. PubMed ID: 16951222
[TBL] [Abstract][Full Text] [Related]
15. Stimulation by Monocyte Chemoattractant Protein-1 Modulates the Ex-vivo Colony Formation by Head and Neck Squamous Cell Carcinoma Cells.
Wichmann G; Körner C; Boehm A; Mozet C; Dietz A
Anticancer Res; 2015 Jul; 35(7):3917-24. PubMed ID: 26124338
[TBL] [Abstract][Full Text] [Related]
16. DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC)--potential implications for clinical management and treatment decisions.
Hass HG; Schmidt A; Nehls O; Kaiser S
Oral Oncol; 2008 Jan; 44(1):78-85. PubMed ID: 17350326
[TBL] [Abstract][Full Text] [Related]
17. Increased sensitivity to bleomycin in upper aerodigestive tract mucosa of head and neck squamous cell carcinoma patients.
Jin C; Jin Y; Wennerberg J; Rosenquist B; Mertens F
Mutat Res; 2008 Mar; 652(1):30-7. PubMed ID: 18243046
[TBL] [Abstract][Full Text] [Related]
18. Elevated expression of TGF-beta1 in head and neck cancer-associated fibroblasts.
Rosenthal E; McCrory A; Talbert M; Young G; Murphy-Ullrich J; Gladson C
Mol Carcinog; 2004 Jun; 40(2):116-21. PubMed ID: 15170816
[TBL] [Abstract][Full Text] [Related]
19. [Chemosensitivity testing of anticancer agents in head and neck tumors. I: Comparison between head and neck squamous cell cancers and thyroid cancers].
Nakashima T; Tomita K; Kuratomi Y; Maehara Y; Kohnoe S
Gan To Kagaku Ryoho; 1990 Jan; 17(1):79-84. PubMed ID: 2297240
[TBL] [Abstract][Full Text] [Related]
20. Generation and molecular characterization of head and neck squamous cell lines of fanconi anemia patients.
van Zeeburg HJ; Snijders PJ; Pals G; Hermsen MA; Rooimans MA; Bagby G; Soulier J; Gluckman E; Wennerberg J; Leemans CR; Joenje H; Brakenhoff RH
Cancer Res; 2005 Feb; 65(4):1271-6. PubMed ID: 15735012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
